Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China · Delayed Price · Currency is CNY 25.40
+0.22 (0.87%)
At close: Jan 23, 2026
SHA:688298 Revenue
Zhejiang Orient Gene Biotech had revenue of 268.73M CNY in the quarter ending September 30, 2025, with 12.26% growth. This brings the company's revenue in the last twelve months to 842.11M, up 2.00% year-over-year. In the year 2024, Zhejiang Orient Gene Biotech had annual revenue of 827.92M with 0.95% growth.
Revenue (ttm)
842.11M
Revenue Growth
+2.00%
P/S Ratio
5.83
Revenue / Employee
370.00K
Employees
2,276
Market Cap
4.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 827.92M | 7.76M | 0.95% |
| Dec 31, 2023 | 820.16M | -7.95B | -90.65% |
| Dec 31, 2022 | 8.77B | -1.40B | -13.78% |
| Dec 31, 2021 | 10.17B | 6.90B | 211.43% |
| Dec 31, 2020 | 3.27B | 2.90B | 788.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 7.22B |
| Wuhan Huakang Century Clean Technology | 2.06B |
| Getein Biotech | 1.04B |
| Shanghai Kinetic Medical | 1.02B |
| Hangzhou AGS MedTech | 668.70M |
| Chison Medical Technologies | 449.62M |
| Nanjing Medlander Medical Technology | 437.82M |
| Nanjing Vishee Medical Technology | 433.83M |